Fluence Therapeutics
Harnessing the power of light for advanced psoriasis treatment and skin health.
Harnessing the power of light for advanced psoriasis treatment and skin health.
Fluence Therapeutics is a biotechnology startup with a focused mission encapsulated in its slogan, "Harnessing the power of light for advanced psoriasis treatment and skin health." Founded in 2011, the company has its roots in Case Western Reserve University and University Hospitals Case Medical Center in Cleveland, Ohio, USA. It is at the forefront of advancing the commercialization of photodynamic therapy (PDT) for the treatment of psoriasis and various other skin conditions. The last investment received by the company was a $150.00K Seed Round investment on 03 May 2013, with no disclosed investors. Fluence Therapeutics operates within the Biotechnology and Life Sciences industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $150.00K | - | 03 May 2013 |
No recent news or press coverage available for Fluence Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
